ENDOCLOT PLUS
EndoClot Plus, Inc. (EPI) is a privately held medical device company in Santa Clara, California. In collaboration with endoscopists and biomaterial scientists, EPI developed EndoClot® Polysaccharide Hemostatic System (EndoClot® PHS), a breakthrough technology to control bleeding in the gastrointestinal tract by spraying a proprietary powder directly to the wound during endoscopy. In 2014, EndoClot Plus Co., Ltd. was established in Suzhou Industrial Park, China to manufacture the EndoClot® pr... oduct lines including EndoClot® PHS, EndoClot® Adhesive and EndoClot® Submucosal Injection System. EndoClot Plus has both clinical and biomaterial expertise and is continuously developing medical devices to meet the needs of the GI professional. The mission of EndoClot Plus is to become the leading company in creating new biomaterial therapeutic solutions for GI Endoscopy.
ENDOCLOT PLUS
Social Links:
Industry:
Health Care Manufacturing Medical Medical Device
Founded:
2014-01-01
Address:
Santa Clara, California, United States
Country:
United States
Website Url:
http://www.endoclot.com
Total Employee:
11+
Status:
Active
Contact:
(408) 980-9125
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
SSL By Default Apache Google Apps For Business DigiCert SSL RapidSSL Softlayer Name.com DNS
Similar Organizations
Inlet Medical
Inlet Medical Inc., based in Eden Prairie, MN., is a privately held medical device company.
Thorlabs
Thorlabs is a privately held optical equipment company.
ZSX Medical
ZSX Medical, LLC, is a pre-clinical stage medical device company.
Investors List
Ming Bioventures
Ming Bioventures investment in Series B - EndoClot Plus
Official Site Inspections
http://www.endoclot.com
- Host name: hs9.name.tools
- IP address: 169.60.152.50
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "EndoClot Plus"
EndoClot Plus - Crunchbase Company Profile & Funding
EndoClot Plus, Inc. (EPI) is a privately held medical device company in Santa Clara, California. In collaboration with endoscopists and biomaterial scientists, …See details»
EndoClot Plus - Org Chart, Teams, Culture & Jobs - The Org
EndoClot Plus, Inc. (EPI) is a privately held medical device company in Santa Clara, California. In collaboration with endoscopists and biomaterial scientists, EPI developed EndoClot® …See details»
EndoClot
EndoClot Plus, Inc. (EPI) is a privately held medical device company in Santa Clara, California. In collaboration with endoscopists and biomaterial scientists, EPI developed EndoClot ® …See details»
EndoClot Plus - Craft
EndoClot Plus is a medical device company providing therapeutic solutions for GI endoscopy. It develops EndoClot polysaccharide hemostatic system (EndoClot PHS), a technology to …See details»
EndoClot® PHS | Olympus America | Medical
EndoClot Polysaccharide Hemostatic System (PHS) is an advanced powder hemostat that is applied during a procedure using consistent air pressure intended to provide more control of …See details»
Olympus Canada Announces Expansion of Exclusive Distribution …
The expanded partnership further strengthens Olympus' global leadership in hemostasis and EMR and ESD procedures RICHMOND HILL, ON, (April 8, 2025) – Olympus Canada Inc. …See details»
EndoClot® Submucosal Injection Solution (SIS)
EndoClot® SIS is designed to deliver a long-lasting mucosal lift with higher elevation and easy delivery. Submucosal Injection Solution (SIS) approaches lifting differently by being composed …See details»
EndoClot®- Polysaccharide Hemostatic System (PHS) - SAGES
Jul 27, 2021 EndoClot Plus, Inc. (EPI) received clearance for the EndoClot® – Polysaccharide Hemostatic System (PHS) from the Food and Drug Administration (FDA) in January 2021. The …See details»
Olympus Canada Announces Expansion of Exclusive Distribution
RICHMOND HILL, ON, April 8, 2025 /CNW/ -- Olympus Canada Inc. (OCI) announced today the expansion of Olympus' commercial partnership with EndoClot® Plus, Inc. (EPI) to include …See details»
Advances in Hemostatic Management for Endoscopic Procedures: …
Apr 7, 2025 EndoClot Adhesive is an innovative hemostatic spray with a composition and mechanism of action that distinguish it from other available agents. The Adhesive Hemostatic …See details»
EndoClot
EndoClot ® Polysaccharide Hemostatic System (EndoClot ® PHS). EndoClot ® PHS is a single use medical device consisting of Absorbable Modified Polymers (AMP ®) and a unique …See details»
EndoClot FAQ
5201 Great America Parkway, Suite 526, Santa Clara, CA 95054, USA Phone: +1 (408) 980-9125 E-mail: [email protected] ® What is EndoClot® PHS? EndoClot® PHS (Polysaccharide …See details»
Submucosal Injection – Vitramed
EndoClot ® Submucosal Injection System (SIS) is a single-use medical device that is composed of Absorbable Modified Polymer (AMP ®) derived from plant starch particles in a vial and a …See details»
Providing Effective Hemostasis Using EndoClot ® Technology in ...
Apr 7, 2025 Providing Effective Hemostasis Using EndoClot ® Technology in Endoscopic Procedures Despite their overall effectiveness, established interventions for providing …See details»
Polymer Technology - EndoClot
AMP ® technology is a proprietary engineering process that modifies plant starch into biocompatible, absorbable hemostatic polysaccharide. AMP ® particles have a molecular …See details»
Olympus Canada Announces Expansion of Exclusive Distribution …
Apr 8, 2025 This agreement follows a successful commercialization of the EndoClot portfolio in the United States and in Europe, Middle East and Africa (EMEA). EndoClot Adhesive is a …See details»
Olympus Distribution of EndoClot® Showing Steady Adoption in …
EndoClot products are used by more than 700 accounts, including most of the country’s top-ranked (by size) Integrated Delivery Networks (IDNs) CENTER VALLEY, Pa., (March 1, 2024) …See details»
EndoClotPlus
EndoClot ® Submucosal Injection System. EndoClot ® Submucosal Injection System (SIS) is a single-use medical device that is composed of Absorbable Modified Polymer (AMP®) derived …See details»
Optimizing Visualization and Hemostasis During Endoscopy
May 30, 2025 This article highlights the benefits of using RDI â„¢ technology and EndoClot ® PHS to optimize visibility and identify bleeding points and deep blood vessels to maintain …See details»
www.endoclot.com
Www.endoclot.comSee details»